CoChat
Sign Up
Cited by 535Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

HbA 1c as a screening tool for detection of Type 2 diabetes: a systematic review

Bennett, C. M., Guo, M., Dharmage, S. C.·2007·Diabetic Medicine
DOI 10.1111/j.1464-5491.2007.02106.x
Open this paper in CoChat — free account

Abstract

Aim To assess the validity of glycated haemoglobin A(1c) (HbA(1c)) as a screening tool for early detection of Type 2 diabetes. Methods Systematic review of primary cross-sectional studies of the accuracy of HbA(1c) for the detection of Type 2 diabetes using the oral glucose tolerance test as the reference standard and fasting plasma glucose as a comparison. RESULTS Nine studies met the inclusion criteria. At certain cut-off points, HbA(1c) has slightly lower sensitivity than fasting plasma glucose (FPG) in detecting diabetes, but slightly higher specificity. For HbA(1c) at a Diabetes Control and Complications Trial and UK Prospective Diabetes Study comparable cut-off point of > or = 6.1%, the sensitivity ranged from 78 to 81% and specificity 79 to 84%. For FPG at a cut-off point of > or = 6.1 mmol/l, the sensitivity ranged from 48 to 64% and specificity from 94 to 98%. Both HbA(1c) and FPG have low sensitivity for the detection of impaired glucose tolerance (around 50%). CONCLUSIONS HbA(1c) and FPG are equally effective screening tools for the detection of Type 2 diabetes. The HbA(1c) cut-off point of > 6.1% was the recommended optimum cut-off point for HbA(1c) in most reviewed studies; however, there is an argument for population-specific cut-off points as optimum cut-offs vary by ethnic group, age, gender and population prevalence of diabetes. Previous studies have demonstrated that HbA(1c) has less intra-individual variation and better predicts both micro- and macrovascula…

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2007.02106.x

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Research works printed but not linked: 1

  1. Little RR, 1998, A simple blood collection device for analysis of glycohemoglobin (GHB), Clin Chem, 44, A

Cited by

Sorted by citations

Items 401–500 of 535

Related

See all

Metadata

Authors
Bennett, C. M., Guo, M., & Dharmage, S. C.
Affiliations
The University of Melbourne (AU)
Corresponding author
Bennett, C. M.
ORCID
Venue
Diabetic Medicine
Publisher
Wiley
Published
2007-03-15
Volume
24
Issue
4
Pages
333-343
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
DOI
10.1111/j.1464-5491.2007.02106.x
OpenAlex
W2105093768
Cited by
534
References
44
Citations by year
2026: 12 · 2025: 13 · 2024: 30 · 2023: 15 · 2022: 25 · 2021: 15 · 2020: 25 · 2019: 24 · 2018: 31 · 2017: 28 · 2016: 33 · 2015: 31 · 2014: 38 · 2013: 39 · 2012: 33
FWCI
4.65
Type
journal article
Language
en
Update notices
erratum (2007-08-21)
Open access
closed
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations
  • Diabetic Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
glycated haemoglobin A1c, type 2 diabetes screening, fasting blood glucose, diagnostic accuracy, sensitivity and specificity, impaired glucose tolerance, cut-off values, oral glucose tolerance test, cost-effectiveness
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Male, Middle Aged, Predictive Value of Tests, Reference Standards, ROC Curve, Sensitivity and Specificity, Biomarkers, Prevalence, Likelihood Functions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review